GUT-C PLUS Capsule Philippines - English - FDA (Food And Drug Administration)

gut-c plus capsule

n/a; importer: n/a; distributor: rm lorenzo pharma & distribution inc. - ascorbic acid , zinc - capsule - 500mg (equivalent to 605.33mg calcium ascorbate) / 10mg (equivalent to 27.44mg zinc sulfate monohydrate)

CVS PHARMACY QUICK RELIEF- zinc oxide cream United States - English - NLM (National Library of Medicine)

cvs pharmacy quick relief- zinc oxide cream

cvs pharmacy - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide .013 g in 1 g - purpose skin protectant uses - helps treat and prevent diaper rash - protects chafed skin due to diaper rash and helps seal out wetness

COLD-EEZE PLUS NIGHTTIME MULTI-SYMPTOM RELIEF- zinc gluconate, eupatorium perfoliatum flowering top, sambucus nigra flower, vale United States - English - NLM (National Library of Medicine)

cold-eeze plus nighttime multi-symptom relief- zinc gluconate, eupatorium perfoliatum flowering top, sambucus nigra flower, vale

prophase labs, inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37), eupatorium perfoliatum flowering top (unii: 1w0775vx6e) (eupatorium perfoliatum flowering top - unii:1w0775vx6e), sambucus nigra flower (unii: 07v4dx094t) (sambucus nigra flower - unii:07v4dx094t), valerian (unii: jwf5yaw3qw) (valerian - unii:jwf5yaw3qw), chamomile (unii: fgl3685t2x) (chamomile - unii:fgl3685t2x), mentha piperita (unii: 79m2m2uda9) (mentha piperita - unii:79m2m2uda9), myrrh (unii: jc71gj1f3l) (myrrh - unii:jc71gj1f3l) - zinc gluconate 1 [hp_x] - - to reduce the duration of the common cold - reduces the severity of cold and flu symptoms: cough, sore throat, nasal and chest congestion, post nasal drip and/or hoarseness - helps for temporary relief of sore throat - helps to relax and sleep easier to get rested

V-Strong Softgel Capsule Philippines - English - FDA (Food And Drug Administration)

v-strong softgel capsule

medinova pharmaceutical inc.; distributor: rm lorenzo pharma & distribution inc. - multivitamins , minerals - softgel capsule - formulation: each softgel capsule contains: retinyl palmitate (vitamin a) cholecalciferol (vitamin d3) pyridoxine (vitamin b6) thiamine (vitamin b1) riboflavin (vitamin b2) cyanocobalamin (vitamin b12) alpha tocopheryl acetate (vitamin e) calcium pantothenate (vitamin b5) nicotinamide (vitamin b3) folic acid (vitamin b9) 2500iu calcium and phosphorus (dibasic calcium phosphate) 200iu iron (dried ferrous sulphate) 1.34mg magnesium (magnesium sulphate) img potassium (potassium sulphate) img zinc (zinc sulphate) imcg molybdenum (sodium molybdate) 5mg copper (copper sulphate) img iodine (potassium iodide) 15mg manganese (manganese sulphate) 50mcg img 0.15mg 0.1mg 0.01mg 0.0015mg 0.05mg

MEIJER KIDS TEAR FREE SPF 50- titanium dioxide, zinc oxide lotion United States - English - NLM (National Library of Medicine)

meijer kids tear free spf 50- titanium dioxide, zinc oxide lotion

meijer distribution, inc. - titanium dioxide  3.2%, zinc oxide 4.0% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

COLD-EEZE PLUS NATURAL MULTI-SYMPTOM RELIEF- zinc gluconate, sambucus nigra flower, and glycyrrhiza glabra leaf lozenge United States - English - NLM (National Library of Medicine)

cold-eeze plus natural multi-symptom relief- zinc gluconate, sambucus nigra flower, and glycyrrhiza glabra leaf lozenge

mylan consumer healthcare, inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37), sambucus nigra flower (unii: 07v4dx094t) (sambucus nigra flower - unii:07v4dx094t), glycyrrhiza glabra leaf (unii: gh32m797y9) (glycyrrhiza glabra leaf - unii:gh32m797y9) - cold remedy relieves cough, nasal congestion and irritated respiratory tract* relieves irritated throat* taking minocycline, doxycycline, tetracycline or are on coumadin (warfarin) therapy. zinc treatment may inhibit the absorption of these medicines. symptoms persist beyond 7 days

Diclofenac (as sodium) -DRP-5152-01 50mg Enteric-Coated Tablet Philippines - English - FDA (Food And Drug Administration)

diclofenac (as sodium) -drp-5152-01 50mg enteric-coated tablet

rm lorenzo pharma & distribution inc. - diclofenac (as sodium) - enteric-coated tablet - 50mg

ZOLPIDEM- zolpidem tartrate tablet United States - English - NLM (National Library of Medicine)

zolpidem- zolpidem tartrate tablet

hikma pharmaceuticals usa inc. - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate 5 mg - zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see clinical studies (14) ]. the clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpidem tartrate is contraindicated in patients with known hypersensitivity to zolpidem tartrate or to any of the inactive ingredients in the formulation. observed reactions include anaphylaxis and angioedema [see warnings and precautions (5.2)]. there are no adequate and well-controlled studies in pregnant women. zolpidem tartrate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. administration of zolpidem to pregnant rats and rabbits resulted in adverse effects on offspring development at doses greater than the zo

VALCHLOR- mechlorethamine hydrochloride gel United States - English - NLM (National Library of Medicine)

valchlor- mechlorethamine hydrochloride gel

actelion pharmaceuticals us, inc. - mechlorethamine (unii: 50d9xsg0vr) (mechlorethamine - unii:50d9xsg0vr) - mechlorethamine 0.012 g in 60 g - valchlor is an alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides-type cutaneous t-cell lymphoma in patients who have received prior skin-directed therapy. the use of valchlor is contraindicated in patients with known severe hypersensitivity to mechlorethamine. hypersensitivity reactions, including anaphylaxis, have occurred with topical formulations of mechlorethamine. pregnancy category d [see warnings and precautions (5.5) ] risk summary mechlorethamine can cause fetal harm when administered to a pregnant woman. there are case reports of children born with malformations in pregnant women systemically administered mechlorethamine. mechlorethamine was teratogenic in animals after a single subcutaneous administration. if this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus [see warnings and precautions (5.5) ]. animal data mechlorethamine caused fetal malformat

DIVALPROEX SODIUM EXTENDED RELEASE- divalproex sodium tablet, extended release United States - English - NLM (National Library of Medicine)

divalproex sodium extended release- divalproex sodium tablet, extended release

zydus pharmaceuticals usa inc - divalproex sodium (unii: 644vl95ao6) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg - divalproex sodium extended-release tablets are a valproate and are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. a manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. a mixed episode is characterized by the criteria for a manic episode in conjunction with those for a major depressive episode (depressed mood, loss of interest or pleasure in nearly all activities). the efficacy of divalproex sodium extended-release tablets are based in part on studies of divalproex sodium delayed release tablets in this indication, and was confirmed in a 3-week trial with patients meeting dsm-iv tr criteria for bipolar i disorder, manic or mixed type, who were hospitalized for acute mania [see clinical studies